Home > Communications > Burden of disease modelling
Burden of Disease Modelling
Burden of disease models establish the need for your product in a responsible and resource focused fashion.
The first step in establishing a need for a new agent is to characterise the disease area itself. This will require identification of disease prevalence, incidence, morbidity and mortality, as well as an appraisal of the resource impact of current management paradigms. By then placing the new proposal within this model, one can make a reasoned case for its adoption. This approach is particularly valuable where a disease attracts little priority, or where the new therapy offers a substantial clinical or safety benefit.
JBM's burden of disease models identify the scope for opportunity beyond the established market in a fashion aligned to product strategy, and will provide access to key non-prescribing service commissioners.
